March 20 (Reuters) – Spire Healthcare said on Friday that buyout talks with private equity firms Bridgepoint and Triton have ended, but it was still in discussions with other parties for a potential sale.
“There can be no certainty that any offer will be made for the company nor as to the terms of any offer, if made,” Spire said in a statement.
Bridgepoint and Triton said earlier on Friday that they have no intentions of making an offer for the private hospital group. Spire had said in January it was exploring strategic options with several firms, including Bridgepoint and Triton.
In its statement, Bridgepoint said it has been unable to arrive at a transaction structure that would work for all stakeholders at this time. Triton did not specify any reasons for its decision.
Spire added that its board and management are also evaluating “other appropriate actions to drive long-term, sustainable shareholder value”.
Sky News had reported on Thursday that Bridgepoint was drawing up proposals worth more than 1 billion pounds ($1.34 billion) for Spire.
Spire, which operates 38 hospitals and more than 50 clinics, medical centers and consulting rooms in the UK, has a market valuation of 765.2 million pounds ($1.02 billion), according to LSEG data.
The company’s shares have fallen over 8% since it first confirmed a strategic review of its operations in September 2025.
In 2021, Spire shareholders had rejected a 2.50 pound-per-share bid from Australia’s Ramsay Health Care, arguing it undervalued the business.
($1 = 0.7496 pounds)
(Reporting by Atharva Singh and Rajveer Singh Pardesi; Editing by Maju Samuel, Jonathan Ananda and Shailesh Kuber)
Comments